Piet Wigerinck
Directeur/Bestuurslid bij IPSEN
Vermogen: 89 028 $ op 31-05-2024
Actieve functies van Piet Wigerinck
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
IPSEN | Directeur/Bestuurslid | 01-05-2018 | - |
Independent Dir/Board Member | 01-05-2018 | - | |
University Hospital Antwerp
University Hospital Antwerp Hospital/Nursing ManagementHealth Services University Hospital Antwerp provides clinical, patient care, academic training and scientific research services. The company was is headquartered in Belgium. | Directeur/Bestuurslid | - | - |
miDIAGNOSTICS NV
miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium. | Directeur/Bestuurslid | - | - |
Independent Dir/Board Member | - | - | |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Directeur/Bestuurslid | - | - |
Independent Dir/Board Member | - | - | |
Symeres BV
Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Directeur/Bestuurslid | - | - |
Loopbaan van Piet Wigerinck
Eerdere bekende functies van Piet Wigerinck
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
GALAPAGOS NV | Hoofd Techniek/Wetenschap/O&O | 19-04-2012 | 31-12-2021 |
Corporate Officer/Principal | 01-04-2008 | 19-04-2012 | |
UZA Foundation | Directeur/Bestuurslid | - | - |
Xinvento BV
Xinvento BV BiotechnologyHealth Technology Part of Rhythm Pharmaceuticals, Inc., Xinvento BV is a Dutch biotech company that develops therapies for congenital hyperinsulinism. The company is based in Amsterdam, Netherlands. The company was founded in 2021 by Claudine van der Sande, Sarah Hafith-de Boer, Piet Wigerinck. Claudine van der Sande has been the CEO since 2021. Xinvento was acquired by Rhythm Pharmaceuticals Netherlands BV on February 27, 2023 for $222.43 million. | Oprichter | - | - |
Tibotec-Virco Comm Va | Corporate Officer/Principal | - | - |
░░░░ ░░░░░░░░░ ░ ░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Opleiding van Piet Wigerinck
Katholieke Universiteit Leuven | Doctorate Degree |
Statistieken
Internationaal
België | 7 |
Nederland | 3 |
Singapore | 2 |
Operationeel
Director/Board Member | 6 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 3 |
Sectoraal
Health Technology | 6 |
Commercial Services | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GALAPAGOS NV | Health Technology |
IPSEN | Health Technology |
Bedrijven in privébezit | 8 |
---|---|
Drug Discovery & Development Solutions Ltd.
Drug Discovery & Development Solutions Ltd. Miscellaneous Commercial ServicesCommercial Services Drug Discovery & Development Solutions Ltd. engages in the provision of financial services. The company is headquartered in Singapore. | Commercial Services |
Tibotec-Virco Comm Va | |
University Hospital Antwerp
University Hospital Antwerp Hospital/Nursing ManagementHealth Services University Hospital Antwerp provides clinical, patient care, academic training and scientific research services. The company was is headquartered in Belgium. | Health Services |
miDIAGNOSTICS NV
miDIAGNOSTICS NV Miscellaneous Commercial ServicesCommercial Services miDIAGNOSTICS NV develops a computer chip powered portable medical laboratory. The company is headquartered in Leuven, Belgium. | Commercial Services |
Xinvento BV
Xinvento BV BiotechnologyHealth Technology Part of Rhythm Pharmaceuticals, Inc., Xinvento BV is a Dutch biotech company that develops therapies for congenital hyperinsulinism. The company is based in Amsterdam, Netherlands. The company was founded in 2021 by Claudine van der Sande, Sarah Hafith-de Boer, Piet Wigerinck. Claudine van der Sande has been the CEO since 2021. Xinvento was acquired by Rhythm Pharmaceuticals Netherlands BV on February 27, 2023 for $222.43 million. | Health Technology |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Atriva Therapeutics GmbH is a biopharmaceutical company that develops host-targeting antiviral therapies. It focuses on the development of new antiviral therapies against different respiratory viral infections. The company was founded by Rainer Lichtenberger and Henrik Luer Lueßen in April 2015 and is headquartered in Tuebingen, Germany. | Health Technology |
UZA Foundation | |
Symeres BV
Symeres BV Pharmaceuticals: OtherHealth Technology Symeres provides molecule contract research, discovery, development and manufacturing services. The firm offers discovery chemistry, medicinal chemistry, early process research and GMP production services. The company is headquartered in Groningen, the Netherlands. | Health Technology |
- Beurs
- Insiders
- Piet Wigerinck
- Ervaring